Bracco

Bracco is a multinational life science company that develops, manufactures and markets contrast agents, medical devices and advanced solutions for diagnostic imaging. Founded in 1927, the group employs around 4,000 people and operates in more than 100 countries, with annual revenue of approximately €2.0 billion.

The company's technical work spans contrast media, medical devices for diagnostic imaging applications, precision medicine, prevention and imaging diagnostics research. It maintains 11 innovation centres worldwide and holds over 2,500 active patents, while reinvesting roughly 8% of turnover in research and development. Its product lines include contrast agents intended to improve the diagnostic imaging journey for clinicians and patients, medical devices for imaging applications, and newer diagnostic techniques and solutions, including work framed around sustainability.

Bracco describes its purpose as starting and ending with people, and states an ambition to contribute to the future of prevention and precision medicine. For candidates, the company combines a long corporate heritage, dating back to 1927, with sustained investment in R&D and a global research footprint across life sciences, pharmaceuticals, healthcare and medical devices.